Clinical trial
The Efficacy, Safety And Toleration Of CP-866,087 In Pre-Menopausal Women With…
NCT00482664 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00482664 |
|---|---|
| Title | The Efficacy, Safety And Toleration Of CP-866,087 In Pre-Menopausal Women With Female Sexual Arousal Disorder. |
| Official title | A Phase 2a Multi-Centre, Double Blind, Placebo Controlled Cross-Over Trial To Investigate The Efficacy, Safety And Toleration Of CP-866,087 In Pre-Menopausal Women Diagnosed With Female Sexual Arousal Disorder (FSAD). |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Sexual Dysfunction, Physiological |
| Intervention type | Drug |
| Interventions | CP-866, 087, Placebo |
| Enrollment | 84 |
| Start date | Jul 1, 2007 |
| Primary completion | Sep 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | Jun 5, 2007 |
| Last update posted | Nov 1, 2010 |
| Countries | Australia, Denmark, Norway, South Africa, Sweden |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: